1. Volume 149, Issue 6, Pages 1462-1470 (November 2015)
Efficacy of Sofosbuvir Plus Ribavirin With or Without Peginterferon-Alfa in Patients With Hepatitis C Virus Genotype 3 Infection and Treatment-Experienced Patients With Cirrhosis and Hepatitis C Virus Genotype 2 Infection 
Graham R. Foster, Stephen Pianko, Ashley Brown, Daniel Forton, Ronald G. Nahass, Jacob George, Eleanor Barnes, Diana M. Brainard, Benedetta Massetto, Ming Lin, Bin Han, John G. McHutchison, G. Mani Subramanian, Curtis Cooper, Kosh Agarwal 
Gastroenterology 
Volume 149, Issue 6, Pages (November 2015)
DOI: /j.gastro
Copyright © 2015 AGA Institute Terms and Conditions

2. Figure 1
Rates of SVR12 by subgroup in patients with genotype 3 HCV. The position of the squares indicates the rate of virologic response 12 weeks after the end of treatment in the subgroup. Horizontal lines indicate 95% confidence intervals. Vertical lines represent the overall rates of SVR.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2015 AGA Institute Terms and Conditions